Last reviewed · How we verify
L+E maxillary anesthesia
L+E maxillary anesthesia is a local anesthetic formulation designed to provide regional anesthesia in the maxillary region of the oral cavity.
L+E maxillary anesthesia is a local anesthetic formulation designed to provide regional anesthesia in the maxillary region of the oral cavity. Used for Local anesthesia for maxillary dental and oral surgical procedures.
At a glance
| Generic name | L+E maxillary anesthesia |
|---|---|
| Sponsor | University of Belgrade |
| Drug class | Local anesthetic |
| Modality | Small molecule |
| Therapeutic area | Anesthesia / Dentistry |
| Phase | Phase 3 |
Mechanism of action
This appears to be a combination local anesthetic preparation (likely lidocaine and epinephrine based on the 'L+E' designation) intended for maxillary nerve block or infiltration anesthesia in dental and oral surgical procedures. The formulation combines a local anesthetic agent with a vasoconstrictor to prolong duration and reduce systemic absorption.
Approved indications
- Local anesthesia for maxillary dental and oral surgical procedures
Common side effects
- Transient paresthesia
- Injection site discomfort
- Allergic reaction (rare with amide anesthetics)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L+E maxillary anesthesia CI brief — competitive landscape report
- L+E maxillary anesthesia updates RSS · CI watch RSS
- University of Belgrade portfolio CI